AstraZeneca bets on in-house AI to speed up oncology research
Drug development is producing more data than ever, and large pharmaceutical companies like AstraZeneca are turning to AI to make sense of it. The challenge is no longer whether AI can help, but how tightly it needs to be built into research and clinical work to improve decisions around trials and treatment. That question helps […]
The post AstraZeneca bets on in-house AI to speed up oncology research appeared first on AI News.
Grab brings robotics in-house to manage delivery costs
Rising labour costs and tighter delivery margins are pushing large platform operators like Grab to look at automation. It’s moved to bring robotics capability in-house by its acquisition of Infermove. Grab operates at a scale where small efficiency gains can have out-sized effects. Its platform supports millions of deliveries in Southeast Asia, many of them […]
The post Grab brings robotics in-house to manage delivery costs appeared first on AI News.